Followers | 6 |
Posts | 1388 |
Boards Moderated | 0 |
Alias Born | 10/08/2009 |
![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, June 22, 2018 10:57:21 AM
============
Pursuant to Listing Rule 17.1, Clinuvel Pharmaceuticals Ltd (CUV) requests an immediate trading halt with respect to its ordinary shares listed on the ASX. The trading halt is necessary as CUV proposes to make an announcement to the market regarding a regulatory submission for its drug SCENESSE®.
CUV requests that trading in its securities be halted until after the expected announcement is made or until the commencement of trade on Tuesday 26th June 2018, whichever is the earlier.
CUV is not aware of any reason why the trading halt should not be granted by the ASX nor is it aware of any other information that is necessary to inform the market about the trading halt.
Does anyone have Level 2 on this one ? Interesting day. Halted in Aus and Germany but not here in the US. Strange move by management.
PickleJar Unveils Latest Venue Managed Services Innovations in Upcoming Webinar • PKLE • Aug 23, 2024 1:11 PM
Element79 Gold Corp Provides Update on Nevada Portfolio • ELMGF • Aug 23, 2024 8:00 AM
Maybacks Adds Award Winning Show to Its Lineup Discusses Maybacks Opportunity • AHRO • Aug 22, 2024 11:30 AM
North Bay Resources Announces First Gold Concentrate at Mt. Vernon Gold Mine, Assays 12 oz/ton Gold, 17.5 oz/ton Platinum, and 8 oz./ton Silver, Sierra County, California • NBRI • Aug 22, 2024 10:28 AM
All Things Mobile Analytic, Inc. Reports Major Growth with Over $11 Million in Revenue • ATMH • Aug 22, 2024 7:19 AM
Unitronix Announces Strategic Entry into Cryptocurrency Space • UTRX • Aug 21, 2024 10:00 AM